NCT05865730View on ClinicalTrials.gov

A Study of Oncobax®-AK in Patients With Advanced Solid Tumors

PHASE2RecruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Carcinoma, Renal CellCarcinoma, Non-Small-Cell Lung
Interventions
OTHER

Live Bacterial Product - Akkermansia muciniphila

Oral administration of Oncobax-AK to patients deficient in Akkermansia by stool metagenomic analysis.

Trial Locations (4)

Unknown

RECRUITING

CHU Ambroise Paré, Mons

RECRUITING

Centre Georges Francois Leclerc, Dijon

RECRUITING

Institut Gustave Roussy, Paris

RECRUITING

ICANS - Institut de cancérologie Strasbourg, Strasbourg

Sponsors

Lead Sponsor

EverImmune
All Listed Sponsors
lead

EverImmune

INDUSTRY